ArticleHemaSphere2025

Retreatment with venetoclax and rituximab following disease progression while off therapy in patients with chronic lymphocytic leukemia.

Danielle M Brander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.